Skip to main content Skip to navigation

PERI-Ox

Hospital ward

The PERI-Ox trial is currently in set-up

Key information

Title:

Perioperative Oxygen in Major Surgery

Chief Investigator: Dr Andrew Cumpstey

Sponsor: University of Southampton NHS Foundation Trust

Funder: NIHR HTA 504358

Registration Number: tbc

Summary:

PERI-Ox is a randomised controlled trial which will investigate the clinical and cost-effectiveness of 3 oxygen interventions given in adults undergoing major abdominal surgery under general anaesthesia. The trial aims to address whether 80% oxygen, 50% oxygen or keeping oxygen saturation (SpO2) ≥94% result in more days alive and out of hospital in the first 90 days after surgery (DAH90). Secondary objectives include which oxygenation strategy results in the lowest incidence of surgical site infections and post-operative pulmonary complications.

Sample size:

5000 participants

Primary outcome:

Days alive and out of hospital at 90 days (DAH90)

Duration:

5 years

Key trial documents

Link to protocol tbc

Link to other document pages tbc

Enquiries:

If you have any questions about the PERI-Ox trial please feel free to contact the trial team.

Trial Manager: Dr Hannah Noordali
Tel: 024 761 50478

Trial Coordinator: Nadia Wustrack-Law
Tel: 024 761 51738

Email: perioxtrial@warwick.ac.uk

Address:
PERI-Ox trial
Warwick Clinical Trials Unit
Warwick Medical School
University of Warwick
Coventry
CV4 7AL

Let us know you agree to cookies